顧客増加は結果です。決定すべきは、繰り返し実行できる費用で済む道筋を選ぶことです。 B2B SaaS企業では、答えを運ぶ数字が純収益維持率とCAC回収期間に現れます。この業界特有の複雑さは、成長率が42%から32%へ低下し、収益の60%が最も経済性の悪いセグメントに集中している点です。問題の一般形と実際に置かれている状況とでは、最初の動きが異なります。
顧客増加は結果です。決定すべきは、繰り返し実行できる費用で済む道筋を選ぶことです。 B2B SaaS企業では、答えを運ぶ数字が純収益維持率とCAC回収期間に現れます。この業界特有の複雑さは、成長率が42%から32%へ低下し、収益の60%が最も経済性の悪いセグメントに集中している点です。問題の一般形と実際に置かれている状況とでは、最初の動きが異なります。
ほとんどの企業は顧客獲得の方法をいくつか挙げられますが、どれが回収できるかを言える企業は少ないものです。実際の制約は戦術の不足ではなく、どの戦術を増やすべきかの根拠がないことです。
有効な枠組みは経路の経済性です。各経路について、顧客1件あたりの獲得コスト、回収までの期間、規模を拡大してもコストが上昇せずに繰り返せるかを確認します。
ほとんどの経路は3つ目の条件を満たしません。小規模では創業者の人脈や注意に依存するため機能しますが、それらが尽きると静かに止まります。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 成長が特定の1人の人脈に依存している
✓ 顧客単価のコストが不明、または集計値でしか把握できていない
✓ すべてのチャネルを少しずつ試しているが、どれも十分に検証されていない
通常、事態を悪化させる対応です。 複数のチャネルを小規模に同時運用すると、どのチャネルからも結論が出ず、1つを十分に検証する場合より費用がかさみます。
It is for you if you run or finance a B2B SaaS company and growth depends on one person's relationships. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on B2B SaaS企業. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For B2B SaaS企業 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
買い手がすでに存在し、獲得コストを自社で融資可能な期間内に回収できるチャネルです。これは事業ごとに異なり、一般論はほとんど役に立ちません。
1つが機能してから2つ目です。必要な予算の4分の1で4つを同時に走らせると、4つの結論が出ない結果と、何も機能しないという思い込みが生まれます。
販売サイクルに回収期間を加えた期間で、結果をノイズと区別できる十分な量が必要です。その数値を事前に決めておくことで、説得力のある人物の判断に左右されなくなります。
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית